NDC 68547-005

Giapreza

Angiotensin Ii

Giapreza is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by La Jolla Pharmaceutical Company. The primary component is Angiotensin Ii.

• Product ID: 68547-005_e235f25b-7a71-d6c3-e053-2995a90aa2a4
• NDC: 68547-005
• Product Type: Human Prescription Drug
• Proprietary Name: Giapreza
• Generic Name: Angiotensin Ii
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-09-15
• Marketing Category: NDA /
• Application Number: NDA209360
• Labeler Name: La Jolla Pharmaceutical Company
• Substance Name: ANGIOTENSIN II
• Active Ingredient Strength: 1 mg/mL
• Pharm Classes: Vasoconstriction [PE], Vasoconstrictor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 68547-005-01

1 VIAL, SINGLE-DOSE in 1 CARTON (68547-005-01) > 1 mL in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2022-09-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Giapreza" or generic name "Angiotensin Ii"

NDC	Brand Name	Generic Name
68547-005	Giapreza	angiotensin II
68547-501	Giapreza	angiotensin II